Melanoma Stage III or IV — Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection
Citation(s)
Active Immunization of Patients With Stage III and IV Melanoma in Whom a Regional Lymph Node Dissection is Planned, With Peptide-Pulsed Dendritic Cells: Evaluation of in Vivo Immune and Clinical Response and Migration